IRIS

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 32
Titolo Data di pubblicazione Autore(i) File
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin 1-gen-2012 Grosso, F; D'Incalci, M; Cartoafa, M; Nieto, A; Fernandez-Teruel, C; Alfaro, V; Lardelli, P; Roy, E; Gomez, J; Kahatt, C; Soto-Matos, A; Judson, I
A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer 1-gen-2014 Chan, S; Campone, M; Santoro, A; Conte, P F; Bostnavaron, M; Nguyen, L
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy 1-gen-2011 Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts 1-gen-2010 Zucchetti, M; Meco, D; Di Francesco, Am; Servidei, T; Patriarca, V; Cusano, G; D'Incalci, M; Forestieri, D; Pisano, C; Riccardi, R
CHANGES IN DOXORUBICIN DISTRIBUTION AND TOXICITY IN MICE PRETREATED WITH THE CYCLOSPORINE ANALOG SDZ-PSC-833 1-gen-1995 Gonzalez, O; Colombo, T; Defusco, M; Imperatori, L; Zucchetti, M; D'Incalci, M
Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells 1-gen-2011 Colombo, V; Lupi, M; Falcetta, F; Forestieri, D; D'Incalci, M; Ubezio, P
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 1-gen-2006 Fruscio, R; Lissoni, Aa; Frapolli, R; Corso, S; Mangioni, C; D'Incalci, M; Zucchetti, M
Clinical and pharmacokinetic study of oral NK611, a new podaphyllatoxin derivative 1-gen-1996 Pagani, O; Zucchetti, M; Sessa, C; Dejong, J; D'Incalci, M; Defusco, M; Kaeserfrohlich, A; Hanauske, A; Cavalli, F
CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS 1-gen-1993 Bramwell, Vhc; Mouridsen, Ht; Santoro, A; Blackledge, G; Somers, R; Verweij, J; Dombernowsky, P; Onsrud, M; Thomas, D; Sylvester, R; Vanoosterom, A
Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin 1-gen-1999 Zucchetti, M; Boiardi, A; Silvani, A; Parisi, I; Piccolrovazzi, S; D'Incalci, M
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma 1-gen-2007 Reni, M; Cereda, S; Bonetto, E; Vigano, Mg; Passoni, P; Zerbi, A; Balzano, G; Nicoletti, R; Staudacher, C; Di Carlo, V
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies 1-gen-2003 Meco, D; Colombo, T; Ubezio, P; Zucchetti, M; Zaffaroni, M; Riccardi, A; Faircloth, G; Jose, J; D'Incalci, M; Riccardi, R
Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin) - An example of potential problems for extrapolation of active drug concentrations from in vitro studies 1-gen-2004 Tognon, G; Frapolli, R; Zaffaroni, M; Erba, E; Zucchetti, M; Faircloth, Gt; D'Incalci, M
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites 1-gen-1998 Ghielmini, M; Colli, E; Bosshard, G; Pennella, G; Geroni, C; Torri, V; D'Incalci, M; Cavalli, F; Sessa, C
IFOSFAMIDE PLUS DOXORUBICIN IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA 1-gen-1993 Schutte, J; Mouridsen, Ht; Steward, W; Santoro, A; Vanoosterom, At; Somers, R; Blackledge, G; Verweij, J; Dombernowsky, P; Thomas, D; Sylvester, R
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer 1-gen-2009 Chiarion-Sileni, V; Innocente, R; Cavina, R; Ruol, A; Corti, L; Pigozzo, J; Del Bianco, P; Fumagalli, U; Santoro, A; Ancona, E
O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITY AND INDUCTION OF NOVEL IMMUNOGENICITY IN MURINE TUMOR-CELLS TREATED WITH METHYLATING AGENTS 1-gen-1992 Bianchi, R; Citti, L; Beghetti, R; Romani, L; D'Incalci, M; Puccetti, P; Fioretti, Mc
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma 1-gen-2009 Reni, M; Cereda, S; Balzano, G; Passoni, P; Rognone, A; Zerbi, A; Nicoletti, R; Mazza, E; Arcidiacono, Pg; Di Carlo, V; Villa, E
PERSPECTIVES ON ANTHRACYCLINES PLUS IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS 1-gen-1993 Casali, P; Pastorino, U; Azzarelli, A; Bertulli, R; Zucchinelli, P; Devizzi, L; Santoro, A
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 1-gen-2017 Ballerini, A; Moro, F; Nerini, If; Marzo, Cm; Di Clemente, A; Ferrari, M; D'Incalci, M; Biondi, A; Colombini, A; Conter, V; Porcu, L; Cervo, L; Rizzari, C; Zucchetti, M
Mostrati risultati da 1 a 20 di 32
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile